Enable Injections Smart EnFuse (IMAGE)

CincyTech

Enable Injections Smart EnFuse

Caption

Enable Injections, Inc., a patient-centric drug delivery combination product company developing advanced wearable devices for subcutaneous delivery of high-volume therapeutics, today announced it has entered into development agreements with Apellis Pharmaceuticals, and most recently, UCB.

Credit

Enable Injections

Usage Restrictions

Can be used in conjunction with this release and coverage of this release.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.